Praziquantel

产品说明书

Print
Chemical Structure| 55268-74-1 同义名 : Embay 8440; (±)-Praziquantel; Traziquantel; Praziquantel, (S)-Isomer; Praziquantel, (R)-Isomer; Praziquantel, (+-)-Isomer; Pyquiton; Cesol; Droncit; Biltricide
CAS号 : 55268-74-1
货号 : A186621
分子式 : C19H24N2O2
纯度 : 98%
分子量 : 312.41
MDL号 : MFCD00058531
存储条件:

Pure form Sealed in dry, store in freezer, under -20°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Praziquantel (PZQ) is the drug of choice for treatment of all human schistosomes. There were marked cure and egg reduction rates, together with mild and short lived side effects of PZQ for treatment of S. haematobium[3]. Praziquantel 40 mg/kg was effective at reducing infection intensity in all Schistosoma species without differences between preschool- and school-aged children[4]. The relative bioavailability of praziquantel injection was 402.5% in contrast to praziquantel tablet. The praziquantel injection has pharmacokinetic characteristics of rapid absorption, high bioavailability and extensive distribution, and the clinical recommended dosage of praziquantel injection is 10 mg/kg[5]. Praziquantel given as an in situ slow-release formulation by subcutaneous injection resulted in concentrations of the active principle in beagle dogs, which should be capable of resisting new Echinococcus infections for at least 6 months[6].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02366884 Neoplasms Phase 2 Enrolling by invitation December 31, 2020 United States, Maryland ... 展开 >> Atavistic Chemotherapy Clinical Trial Bethesda, Maryland, United States, 20814 Mexico Dr. Frank Arguello Cancer Clinic San Jose del Cabo, Baja California Sur, Mexico Instituto de Ciencia y Medicina Genomica Torreon, Coahuila, Mexico 收起 <<
NCT03041766 Schistosomiasis Phase 2 Completed - Senegal ... 展开 >> Biomedical Research Center EPLS Saint Louis, Senegal, BP226 收起 <<
NCT00276224 Schistosomiasis ... 展开 >> Helminthiases Anaemia 收起 << Not Applicable Completed - Zambia ... 展开 >> Kenani and Chandwe School Kenani, Nchelenge district, Zambia 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.20mL

0.64mL

0.32mL

16.00mL

3.20mL

1.60mL

32.01mL

6.40mL

3.20mL

参考文献

[1]Coeli R, Baba EH, et al. Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections. PLoS Negl Trop Dis. 2013 Dec 19;7(12):e2596.

[2]Namwanje H, Kabatereine NB, Olsen A. The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda. Parasitology. 2011 Oct;138(12):1586-92.

[3]Mekonnen A, Legesse M, Belay M, et al. Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia. BMC Res Notes. 2013;6:392. Published 2013 Sep 30

[4]Zwang J, Olliaro P. Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. Parasit Vectors. 2017;10(1):47. Published 2017 Jan 26

[5]Hai-Feng Y, Chuan-Gang Z, Yong-Jun LI, et al. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2017;29(4):431‐435

[6]Jiang B, Zhou XN, Zhang HB, Tao Y, Huo LL, Liu N. Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control. Infect Dis Poverty. 2017;6(1):140. Published 2017 Sep 15